IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 125 filers reported holding IMMUNOVANT INC in Q1 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,537,000 | +1751.8% | 40,041 | +820.7% | 0.00% | – |
| Q2 2023 | $83,000 | +38.3% | 4,349 | +12.1% | 0.00% | – |
| Q1 2023 | $60,000 | -45.0% | 3,879 | -37.2% | 0.00% | – |
| Q4 2022 | $109,000 | +1111.1% | 6,176 | +300.8% | 0.00% | – |
| Q3 2022 | $9,000 | +80.0% | 1,541 | +21.7% | 0.00% | – |
| Q2 2022 | $5,000 | -75.0% | 1,266 | -64.2% | 0.00% | – |
| Q1 2022 | $20,000 | -73.0% | 3,533 | -59.0% | 0.00% | – |
| Q4 2021 | $74,000 | +94.7% | 8,626 | +96.1% | 0.00% | – |
| Q3 2021 | $38,000 | +15.2% | 4,398 | +41.5% | 0.00% | – |
| Q2 2021 | $33,000 | -13.2% | 3,109 | +32.2% | 0.00% | – |
| Q1 2021 | $38,000 | -59.6% | 2,351 | +15.5% | 0.00% | – |
| Q4 2020 | $94,000 | +56.7% | 2,035 | +20.3% | 0.00% | – |
| Q3 2020 | $60,000 | +5900.0% | 1,691 | +3926.2% | 0.00% | – |
| Q2 2020 | $1,000 | – | 42 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 1,439,544 | $27,308,150 | 8.29% |
| Logos Global Management LP | 2,250,000 | $42,682,500 | 5.80% |
| Deep Track Capital, LP | 5,421,330 | $102,842,630 | 4.76% |
| TCG Crossover Management, LLC | 654,853 | $12,422,561 | 2.04% |
| COMMODORE CAPITAL LP | 900,000 | $17,073,000 | 1.92% |
| ACUTA CAPITAL PARTNERS, LLC | 141,755 | $2,689,092 | 1.82% |
| Affinity Asset Advisors, LLC | 260,000 | $4,932,200 | 1.72% |
| HighVista Strategies LLC | 180,320 | $3,420,670 | 1.56% |
| Redmile Group, LLC | 1,921,152 | $36,444,253 | 1.40% |
| Perceptive Advisors | 2,523,783 | $47,876,164 | 1.39% |